RTI-371, formerly known as RTI-4229-371, is a potent and selective dopamine reuptake inhibitor in vitro. RTI-371 and several other DAT-selective inhibitors with atypical actions on locomotor behaviour increased the efficacy of CP55940 in a concentration-dependent manner. References: Navarro HA, Howard JL, Pollard GT, Carroll FI. Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter. Br J Pharmacol. 2009 Apr;156(7):1178-84. doi: 10.1111/j.1476-5381.2009.00124.x. PubMed PMID: 19226282; PubMed Central PMCID: PMC2697692.

纯度：≥98%

CAS：652978-45-5